
### [MONDO:0015870](http://purl.obolibrary.org/obo/MONDO_0015870)
**Label:** rare malignant breast tumor

**Subclasses:** [MONDO:0015442](http://purl.obolibrary.org/obo/MONDO_0015442) (hereditary breast and ovarian cancer syndrome), [MONDO:0006043](http://purl.obolibrary.org/obo/MONDO_0006043) (metaplastic breast carcinoma), [MONDO:0016419](http://purl.obolibrary.org/obo/MONDO_0016419) (hereditary breast carcinoma), 

**Corr. equiv. classes:** [Orphanet:145](http://www.orpha.net/ORDO/Orphanet_145), [OMIM:114480](http://purl.obolibrary.org/obo/OMIM_114480), [Orphanet:213531](http://www.orpha.net/ORDO/Orphanet_213531), [Orphanet:227535](http://www.orpha.net/ORDO/Orphanet_227535), 

**Class expressions from DL-Learner:**

- [HP:0030406](http://purl.obolibrary.org/obo/HP_0030406) (Primary peritoneal carcinoma) 62.50%
- [HP:0100615](http://purl.obolibrary.org/obo/HP_0100615) (Ovarian neoplasm) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 62.50%
- [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 62.50%
- [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 62.50%
- [HP:0030406](http://purl.obolibrary.org/obo/HP_0030406) (Primary peritoneal carcinoma) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 62.50%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 62.50%
- [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) and [HP:0100615](http://purl.obolibrary.org/obo/HP_0100615) (Ovarian neoplasm) 62.50%
- [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) and [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 62.50%
- [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 62.50%
- [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) and [HP:0030406](http://purl.obolibrary.org/obo/HP_0030406) (Primary peritoneal carcinoma) 62.50%
- [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 62.50%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 62.50%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) 62.50%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 62.50%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) 62.50%


